Hims & Hers Health, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Hims & Hers Health, Inc. (HIMS), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are HIMS insiders buying or selling?
In the last 12 months, Hims & Hers Health, Inc. insiders reported 1 open-market purchase ($1.2M) and 45 sales ($31.1M) — net selling of $29.9M. Since July 2021, Trabud has recorded 337 Form 4 filings for HIMS: 9 buys ($7.2M) and 328 sells ($392.7M).
Source: SEC EDGAR Form 4
What stands out
- The largest open-market purchase in the last 12 months was $1.2M by David B Wells (Director) on May 26, 2026. SEC ↗
- The most recent open-market purchase was reported on May 26, 2026 (4 months ago).
Key Statistics (July 2021 – Oct 15, 2026)
Total Form 4 filings
337
SEC EDGAR
Insider filers
20
Insider buys (9)
$7.2M
Insider sells (328)
$392.7M
Insider sentiment
Net sellingNet insider flow of $385.5M in net selling since July 2021, and $29.9M in net selling over the last 12 months.
Recent HIMS insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Soleil Boughton | Chief Legal Officer | Sale | 3.5K | $29.06 | $100.6K | SEC ↗ |
| Oct 2, 2026 | Oluyemi Okupe | Chief Financial Officer | Sale | 2.0K | $29.70 | $59.4K | SEC ↗ |
| Oct 2, 2026 | Soleil Boughton | Chief Legal Officer | Sale | 3.5K | $29.17 | $101.0K | SEC ↗ |
| Sep 23, 2026 | Oluyemi Okupe | Chief Financial Officer | Sale | 29.3K | $29.95 | $876.8K | SEC ↗ |
| Sep 18, 2026 | Oluyemi Okupe | Chief Financial Officer | Sale | 12.3K | $28.82 | $354.9K | SEC ↗ |
| Sep 17, 2026 | Soleil Boughton | Chief Legal Officer | Sale | 6.2K | $27.86 | $173.7K | SEC ↗ |
| Sep 17, 2026 | Michael Chi | Chief Operating Officer | Sale | 14.0K | $28.39 | $398.2K | SEC ↗ |
| Sep 17, 2026 | Mohamed Elshenawy | CTO | Sale | 8.0K | $28.39 | $225.8K | SEC ↗ |
| Sep 3, 2026 | Soleil Boughton | Chief Legal Officer | Sale | 3.5K | $28.33 | $98.0K | SEC ↗ |
| Aug 20, 2026 | Deborah M. Autor | Chief Policy Officer | Sale | 16.8K | $27.85 | $467.1K | SEC ↗ |
| Aug 20, 2026 | Oluyemi Okupe | Chief Financial Officer | Sale | 4.9K | $29.99 | $148.1K | SEC ↗ |
| Aug 20, 2026 | Soleil Boughton | Chief Legal Officer | Sale | 25.1K | $27.55 | $691.8K | SEC ↗ |
| Aug 18, 2026 | Oluyemi Okupe | Chief Financial Officer | Sale | 64.8K | $34.05 | $2.2M | SEC ↗ |
| Jul 20, 2026 | Oluyemi Okupe | Chief Financial Officer | Sale | 7.2K | $31.99 | $229.2K | SEC ↗ |
| Jul 7, 2026 | Oluyemi Okupe | Chief Financial Officer | Sale | 7.2K | $36.49 | $261.4K | SEC ↗ |
| Jun 23, 2026 | Patrick Harrison Carroll | Chief Medical Officer | Sale | 23.7K | $35.00 | $830.4K | SEC ↗ |
| Jun 23, 2026 | Oluyemi Okupe | Chief Financial Officer | Sale | 18.2K | $34.03 | $619.2K | SEC ↗ |
| Jun 17, 2026 | Michael Chi | Chief Operating Officer | Sale | 14.0K | $31.50 | $441.9K | SEC ↗ |
| Jun 17, 2026 | Irene Becklund | PAO | Sale | 12.1K | $30.72 | $370.5K | SEC ↗ |
| Jun 17, 2026 | Mohamed Elshenawy | CTO | Sale | 30.0K | $31.50 | $946.3K | SEC ↗ |
| May 26, 2026 | David B Wells | Director | Purchase | 48.4K | $24.24 | $1.2M | SEC ↗ |
| May 19, 2026 | Oluyemi Okupe | Chief Financial Officer | Sale | 8.0K | $23.64 | $187.9K | SEC ↗ |
| Apr 22, 2026 | Soleil Boughton | Chief Legal Officer | Sale | 9.5K | $30.00 | $283.9K | SEC ↗ |
| Apr 22, 2026 | Oluyemi Okupe | Chief Financial Officer | Sale | 19.6K | $29.96 | $588.6K | SEC ↗ |
| Apr 20, 2026 | Oluyemi Okupe | Chief Financial Officer | Sale | 54.9K | $26.53 | $1.5M | SEC ↗ |
Showing the 25 most recent of 337 Form 4 filings for Hims & Hers Health, Inc..
Most active HIMS insiders
- Soleil Boughton72 filings
- Oluyemi Okupe58 filings
- Andrew Dudum48 filings
- Michael Chi44 filings
- Irene Becklund36 filings
Ask anything about HIMS insider activity
Use Trabud's AI agent to query Hims & Hers Health, Inc.'s Form 4 history in plain English — "Show me HIMS CEO purchases this year" or compare it against any other ticker.
Open the AI agentHIMS insider trading FAQ
Are Hims & Hers Health, Inc. insiders buying or selling?
In the last 12 months, Hims & Hers Health, Inc. insiders reported 1 open-market purchase ($1.2M) and 45 sales ($31.1M) — net selling of $29.9M. Since July 2021, Trabud has recorded 337 Form 4 filings for HIMS: 9 buys ($7.2M) and 328 sells ($392.7M). Over the full record that is net selling of $385.5M.
How many insiders trade HIMS stock?
20 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Hims & Hers Health, Inc.. The most recent filing was accepted on Oct 15, 2026.
Where does Trabud get HIMS insider trading data?
All HIMS insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.